# EDGAR Filing Document

**Accession Number:** 0002011932
**File Stem:** 0001085146-25-005694
**Filing Date:** 2025-9
**Character Count:** 28474
**Document Hash:** e69c29ca102ac30915ea57256d6c2668
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005694.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001085146-25-005694

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Exome Asset Management LLC
- **CENTRAL INDEX KEY:** 0002011932

**ORGANIZATION NAME:**
- **EIN:** 825491108
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23951
- **FILM NUMBER:** 251284054

**BUSINESS ADDRESS:**
- **STREET 1:** 330 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 212-403-3900

**MAIL ADDRESS:**
- **STREET 1:** 330 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0002011932

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Exome Asset Management LLC

**Address:** 330 MADISON AVENUE, NEW YORK, NY 10017

**Telephone number:** 212-403-3900

**Name of agent for service:** Brianne Shergill

**Agent Address:** 330 MADISON AVENUE, NEW YORK, NY 10017

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-23951

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 5493004D4EX5KUUF8I75

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                        | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                           | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO                                  |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| IMMUNOVANT INC                        | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          44380 |                0 | FOR         |                                    44380 | FOR                         |  |
| HUMANA INC.                           | 444859102 | 04/17/2025     | Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          12643 |                0 | FOR         |                                    12643 | FOR                         |  |
| INTUITIVE SURGICAL, INC.              | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |           5077 |                0 | FOR         |                                     5077 | FOR                         |  |
| ELI LILLY AND COMPANY                 | 532457108 | 05/05/2025     | Approval, on an advisory basis, of the compensation paid to the company's named executive officers                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |           3978 |                0 | FOR         |                                     3978 | FOR                         |  |
| BRISTOL-MYERS SQUIBB COMPANY          | 110122108 | 05/02/2025     | Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          38056 |                0 | FOR         |                                    38056 | FOR                         |  |
| SYNDAX PHARMACEUTICALS, INC           | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         262374 |                0 | FOR         |                                   262374 | FOR                         |  |
| TRAVERE THERAPEUTICS, INC.            | 89422G107 | 05/15/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          67992 |                0 | FOR         |                                    67992 | FOR                         |  |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | 21833P301 | 05/15/2025     | Approval, on an advisory basis, of the executive compensation of the Company's named executive officers                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         188100 |                0 | FOR         |                                   188100 | FOR                         |  |
| PERSONALIS, INC.                      | 71535D106 | 05/16/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         121099 |                0 | FOR         |                                   121099 | FOR                         |  |
| REPLIGEN CORPORATION                  | 759916109 | 05/15/2025     | Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          11158 |                0 | FOR         |                                    11158 | FOR                         |  |
| GERON CORPORATION                     | 374163103 | 05/21/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        2281328 |                0 | AGAINST     |                                  2281328 | FOR                         |  |
| NUVATION BIO INC.                     | 67080N101 | 05/21/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         555376 |                0 | FOR         |                                   555376 | FOR                         |  |
| GE HEALTHCARE TECHNOLOGIES INC.       | 36266G107 | 05/28/2025     | Approval of our named executive officers' compensation in an advisory vote                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          18027 |                0 | FOR         |                                    18027 | FOR                         |  |
| SCHOLAR ROCK HOLDING CORPORATION      | 80706P103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          43795 |                0 | FOR         |                                    43795 | FOR                         |  |
| BEIGENE LTD                           | 07725L102 | 05/12/2025     | On a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |           6500 |                0 | FOR         |                                     6500 | FOR                         | Issuer name change to: BeOne Medicines Ltd. |
| CYTOKINETICS, INCORPORATED            | 23282W605 | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          74978 |                0 | FOR         |                                    74978 | FOR                         |  |
| 89BIO, INC.                           | 282559103 | 05/28/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         255795 |                0 | FOR         |                                   255795 | FOR                         |  |
| DYNE THERAPEUTICS, INC.               | 268180403 | 05/30/2025     | To vote, on an advisory basis, to approve the compensation of our named executive officers                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         232128 |                0 | FOR         |                                   232128 | FOR                         |  |
| PENUMBRA, INC.                        | 70975L107 | 05/28/2025     | To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |           6410 |                0 | FOR         |                                     6410 | FOR                         |  |
| SYNDAX PHARMACEUTICALS, INC           | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         224273 |                0 | FOR         |                                   224273 | FOR                         |  |
| REGENXBIO INC.                        | 75901B107 | 05/30/2025     | Advisory vote on the compensation paid to the Company's named executive officers                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         396749 |                0 | FOR         |                                   396749 | FOR                         |  |
| ESTABLISHMENT LABS HOLDINGS INC.      | G31249108 | 05/23/2025     | To approve, on an advisory basis, the compensation of our named executive officers                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          13100 |                0 | FOR         |                                    13100 | FOR                         |  |
| COGENT BIOSCIENCES, INC.              | 19240Q201 | 06/04/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         489198 |                0 | FOR         |                                   489198 | FOR                         |  |
| APREA THERAPEUTICS, INC.              | 03836J201 | 06/05/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          25872 |                0 | FOR         |                                    25872 | FOR                         |  |
| DISC MEDICINE, INC.                   | 254604101 | 06/11/2025     | To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          46322 |                0 | FOR         |                                    46322 | FOR                         |  |
| BIOCRYST PHARMACEUTICALS, INC.        | 09058V103 | 06/11/2025     | To hold a non-binding, advisory vote regarding executive compensation                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         132884 |                0 | FOR         |                                   132884 | FOR                         |  |
| IONIS PHARMACEUTICALS, INC.           | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         121116 |                0 | FOR         |                                   121116 | FOR                         |  |
| NEKTAR THERAPEUTICS                   | 640268306 | 05/23/2025     | To approve a non-binding advisory resolution regarding our executive compensation                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        1575282 |                0 | FOR         |                                  1575282 | FOR                         |  |
| SAVARA INC.                           | 805111101 | 06/05/2025     | To approve, on an advisory basis, the compensation of our named executives                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         577908 |                0 | FOR         |                                   577908 | FOR                         |  |
| GUARDANT HEALTH, INC.                 | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          97496 |                0 | FOR         |                                    97496 | FOR                         |  |
| TREVI THERAPEUTICS INC                | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         156854 |                0 | FOR         |                                   156854 | FOR                         |  |
| CRINETICS PHARMACEUTICALS INC.        | 22663K107 | 06/11/2025     | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          25834 |                0 | FOR         |                                    25834 | FOR                         |  |
| VIRIDIAN THERAPEUTICS, INC.           | 92829J104 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         176218 |                0 | FOR         |                                   176218 | FOR                         |  |
| PRAXIS PRECISION MEDICINES, INC.      | 74006W207 | 06/26/2025     | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion | SECTION 14A SAY-ON-PAY VOTES |          52803 |                0 | FOR         |                                    52803 | FOR                         |  |
| NATERA, INC.                          | 632307104 | 06/13/2025     | To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          14961 |                0 | FOR         |                                    14961 | FOR                         |  |
| AKEBIA THERAPEUTICS, INC.             | 00972D105 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         142130 |                0 | FOR         |                                   142130 | FOR                         |  |
| ARVINAS, INC.                         | 04335A105 | 06/25/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         167295 |                0 | FOR         |                                   167295 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC             | 28036F105 | 06/13/2025     | Conduct an advisory vote on the compensation of our named executive officers                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          28596 |                0 | FOR         |                                    28596 | FOR                         |  |
| STRUCTURE THERAPEUTICS, INC           | 86366E106 | 06/16/2025     | To approve, on an advisory basis, the compensation of the company's named executive officers, as disclosed in the proxy statement                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          77374 |                0 | FOR         |                                    77374 | FOR                         |  |
| ANAPTYSBIO, INC.                      | 032724106 | 06/17/2025     | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          97696 |                0 | FOR         |                                    97696 | FOR                         |  |
| UNITED THERAPEUTICS CORPORATION       | 91307C102 | 06/26/2025     | Advisory resolution to approve executive compensation                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |           4000 |                0 | FOR         |                                     4000 | FOR                         |  |
| AKERO THERAPEUTICS, INC               | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          30207 |                0 | FOR         |                                    30207 | FOR                         |  |
| BRIDGEBIO PHARMA, INC.                | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         112156 |                0 | FOR         |                                   112156 | FOR                         |  |
| NEWAMSTERDAM PHARMA COMPANY N.V.      | N62509109 | 06/01/2025     | Non-binding, advisory vote to approve the 2024 compensation of named executive officers                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          23154 |                0 | FOR         |                                    23154 | FOR                         |  |
| FULCRUM THERAPEUTICS INC              | 359616109 | 06/26/2025     | A non-binding advisory vote on executive compensation                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         622887 |                0 | FOR         |                                   622887 | FOR                         |  |
| GOSSAMER BIO, INC.                    | 38341P102 | 06/25/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        1022115 |                0 | FOR         |                                  1022115 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Exome Asset Management LLC

**By (Signature):** BRIANNE SHERGILL

**By (Printed Signature):** BRIANNE SHERGILL

**By (Title):** Chief Compliance Officer

**Date:** 08/29/2025